Pricing Log in Create free account

Compass Therapeutics, Inc. (CMPX) vs Molecular Partners AG Sponsored ADR (MOLN)

Compass Therapeutics, Inc. and Molecular Partners AG Sponsored ADR are both Biotechnology companies. Compass Therapeutics, Inc. is the larger, with a market value of $136.7M against $119.2M — 1.1× the size. Across the 8 metrics below, Compass Therapeutics, Inc. leads on 5 and Molecular Partners AG Sponsored ADR on 3.

Valuation

Metric CMPX MOLN Biotechnology median
P/E n/m n/m 10.60
P/S n/m 21.86 9.40
P/B 0.86 1.98 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.40 n/m 0.66
EV/Sales n/m 9.32 9.02
Earnings yield (52.63%) (52.05%) (32.88%)
Free cash flow yield (39.71%) (45.19%) (23.13%)

Profitability

Metric CMPX MOLN Biotechnology median
Gross margin 0.00% 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (56.66%) (71.08%) (51.96%)
Return on assets (47.87%) (58.83%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CMPX MOLN Biotechnology median
Revenue growth (TTM) — (27.99%) 6.76%
EPS growth (last fiscal year) (16.67%) (9.94%) 29.88%
Revenue growth, 5-year CAGR — (23.12%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CMPX MOLN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 11.22 6.46 4.97
Net debt to EBITDA 2.86 1.66 1.01

Dividend

Metric CMPX MOLN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CMPX MOLN Biotechnology median
Market cap 136.65m 119.24m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack